The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Candel Therapeutics Inc’s stock clocked out at $8.82, down -0.11% from its previous closing price of $8.83. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 0.75 million shares were traded. CADL stock price reached its highest trading level at $9.08 during the session, while it also had its lowest trading level at $8.3302.
Ratios:
To gain a deeper understanding of CADL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.77 and its Current Ratio is at 2.77. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 20, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On February 19, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.
On February 07, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.BofA Securities initiated its Buy rating on February 07, 2025, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when FRANCESCA BARONE bought 32,146 shares for $8.83 per share.
PAUL PETER TAK bought 74,106 shares of CADL for $654,356 on Mar 18 ’25. On Mar 18 ’25, another insider, WILLIAM GARRETT NICHOLS, who serves as the Officer of the company, bought 45,316 shares for $8.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 416617088 and an Enterprise Value of 327433760.
Stock Price History:
The Beta on a monthly basis for CADL is -1.19, which has changed by 4.88 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 6.75%, while the 200-Day Moving Average is calculated to be 31.00%.
Shares Statistics:
It appears that CADL traded 1.61M shares on average per day over the past three months and 717100 shares per day over the past ten days. A total of 46.93M shares are outstanding, with a floating share count of 34.49M. Insiders hold about 26.98% of the company’s shares, while institutions hold 33.94% stake in the company. Shares short for CADL as of 1740700800 were 3336698 with a Short Ratio of 2.07, compared to 1738281600 on 2643545. Therefore, it implies a Short% of Shares Outstanding of 3336698 and a Short% of Float of 9.68.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
